Le Lézard
Classified in: Health, Science and technology
Subjects: Contract/Agreement, Product/Service

Atomwise Announces Largest China-US Collaboration for AI Drug Discovery


Atomwise Inc. ("Atomwise"), the leader in artificial intelligence (AI) for drug discovery, today announced a collaboration with Hansoh Pharmaceutical Group Company Limited ("Hansoh Pharma"), a leading biopharmaceutical company in China, to design and discover potential drug candidates for up to eleven undisclosed target proteins in multiple therapeutic areas.

"There is exciting science happening throughout Asia, and enormous potential for leadership in innovative drug discovery," said Dr. Abraham Heifets, CEO of Atomwise. "I am delighted to announce that Hansoh Pharma is our first partner in Asia. Hansoh Pharma is committed to innovation and shares our mission for global impact on patient health," he added.

Scientific teams from Atomwise and Hansoh Pharma will collaborate closely on the programs. The combination of Atomwise's AI technology and medicinal chemistry and protein structure expertise, and Hansoh Pharma's fully integrated research and development, manufacturing and commercial capabilities has the potential to dramatically increase success and compress timelines for drug discovery and clinical development.

Under the terms of the collaboration, Atomwise will receive undisclosed technology access fees, option exercise fees, royalties, and income based on sublicensing or sale of assets created under the collaboration. Based on historical average revenues for small molecule drugs, the total potential value of the deal to Atomwise with success in all projects could reach US$1.5 billion.

About Atomwise
Atomwise Inc. invented the first deep learning AI technology for structure-based small molecule drug discovery. Created in 2012, today Atomwise performs hundreds of projects per year in partnership with some of the world's largest pharmaceutical and agrochemical companies, as well as over a hundred universities and hospitals in 19 countries. Atomwise has raised over $50 million from leading venture capital firms to support the development and application of its AI technology. Learn more at atomwise.com or follow @AtomwiseInc.


These press releases may also interest you

at 21:22
Frax, the world's first algorithmic and fully decentralized stablecoin on the blockchain today announced Stephen Moore, Trump economic advisor and former Federal Reserve nominee, and Ralph Benko, former Reagan deputy general counsel, joined the...

at 21:05
Global payment innovation company Verrency today announced that Ms.Namita Bhide, a seasoned leader in financial services technology, has joined the Company as Commercial Director, Asia Pacific. Based in Singapore, Ms. Bhide will leverage her...

at 21:00
BlueVoyant, an analytics-driven cybersecurity firm with a mission to protect businesses against sophisticated cyber attackers, announced today the expansion of its operations to the Philippines. BlueVoyant officially opened its new office in Manila...

at 21:00
Sungrow, the global leading inverter solution supplier for renewables, has signed an agreement with Israeli solar specialist Kahane Group to distribute the Company's products on the Israeli market, accelerating the global step to fulfill its mission...

at 20:40
Boulder SEO Marketing, a leader among digital marketing and search engine optimization agencies in Denver, today announced that it would host a complimentary introductory SEO training class on Thursday, November 7, 2019, in Denver and online via...

at 20:32
Telecom Argentina S.A. ("Telecom") announced today that it has terminated its previously announced offer to exchange (the "Exchange Offer") any and all of its outstanding 6.500% notes due 2021 (the "Old Notes") for new 9.000% notes due 2025 (the "New...



News published on 11 september 2019 at 20:30 and distributed by: